Your browser doesn't support javascript.
loading
Immunohistochemical CD20-negative change in B-cell non-Hodgkin lymphomas after rituximab-containing therapy.
Maeshima, Akiko Miyagi; Taniguchi, Hirokazu; Fujino, Takahiro; Saito, Yo; Ito, Yuta; Hatta, Shunsuke; Yuda, Sayako; Makita, Shinichi; Fukuhara, Suguru; Munakata, Wataru; Suzuki, Tatsuya; Maruyama, Dai; Izutsu, Koji.
Afiliação
  • Maeshima AM; Department of Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. akmaeshi@ncc.go.jp.
  • Taniguchi H; Department of Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Fujino T; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Saito Y; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Ito Y; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Hatta S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Yuda S; Department of Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Fukuhara S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Suzuki T; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Ann Hematol ; 99(9): 2141-2148, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32451711

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Antígenos CD20 / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Antígenos CD20 / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Ano de publicação: 2020 Tipo de documento: Article